Somewhere in the time it takes you to read this sentence, another child, somewhere in the world, will be diagnosed as myopic.
That’s not hyperbole; it’s roughly where the numbers sit. As you’ll read in this issue, global prevalence estimates suggest short-sightedness now affects around a third of the world’s population, a figure projected to climb towards one in every two people by 2050. In parts of East Asia, myopia rates among school leavers already exceed 80%, and Australia and New Zealand are far from immune, with steadily rising rates recorded in successive population studies here too.
What strikes me, compiling this issue year after year, is how quickly
the scale of the problem has outpaced public understanding of it. Ask most parents what myopia means and you’ll likely hear “needs glasses”. Few realise that each additional dioptre carries measurable lifetime risk of sight-threatening disease, or that the window for meaningfully altering a child’s trajectory is measured in months, not years.
Closing that gap, between what we know clinically and what the public understands, remains one of our field’s most persistent challenges. It sits behind the push to reclassify myopia as a disease rather than a refractive inconvenience, behind the growing sophistication of treatment options now available, and behind a research effort that keeps widening into territory few would have predicted two decades ago.
With Myopia Action Month taking place next month (September), this issue could not be better timed. It’s an opportunity to turn all of the available evidence into conversations, with parents, with schools, with GPs; and to make sure the messaging in your practice is as current as the science behind it (be sure to visit myopiaprofile.com for patient-facing resources to help).
Wherever you sit in eye care, we hope this issue leaves you well prepared for this important annual campaign, and for the conversations ahead, with the families in your chair this week, and for years to come.
Enjoy the issue!
MELANIE KELL Editor
